Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for Cancer, today announced the appointment of three ...

NewBiologix, a technology innovation company pioneering efficient, cost-effective, and scalable production of viral vectors for gene and cell therapy, today released a scientific white paper outlining ...

There was some speculation as the NFL's running back market plummeted that San Francisco 49ers RB Christian McCaffrey could ...

That's why we generated Xcell TM HEK293 complemented with advanced analytics to guarantee the highest quality AAV for transformative therapeutic solutions." Igor Fisch, CEO and co-founder of ...

After a strong start to the 2024 season, the New Orleans Saints faltered down the stretch as their poor depth could not ...

Fintel reports that on March 5, 2025, Oppenheimer initiated coverage of Abeona Therapeutics (NasdaqCM:ABEO) with a Outperform ...

The Detroit Lions enter a critical offseason in 2025. Here are three approaches they could take to free agency, the draft and ...

Mathieu Olivier has set career highs, bolstered his fighting reputation and earned a six-year deal from the Blue Jackets worth $18 million.

Phase 1 Dose Expansion Initiated for FT819 Off-the-Shelf CAR T-cell Product Candidate with Fludarabine-free Conditioning in ...

The Tampa Bay Lightning acquired forwards Oliver Bjorkstrand and Yanni Gourde on Wednesday as part of a three-team swap.

Follow along here during the entire final day of NHL trade action for news and analysis of all the biggest moves.

Zeitler likely won't break the bank in terms of years or AAV, making it a viable option for Detroit. Onwuzurike stayed fully healthy in 2024 and turned into a key piece of the maligned Lions ...